Roberts, Glore & Co’s Amgen AMGN Stock Holding History

Roberts, Glore & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.45M	Sell	6,771 -115	-2%	-$39.4K	0.61%	42
2026 Q1	$2.42M	Sell	6,886 -261	-4%	-$93K	0.67%	41
2025 Q4	$2.34M	Sell	7,147 -319	-4%	-$101K	0.62%	38
2025 Q3	$2.11M	Sell	7,466 -108	-1%	-$31.3K	0.58%	44
2025 Q2	$2.11M	Sell	7,574 -15	-0.2%	-$4.25K	0.62%	43
2025 Q1	$2.36M	Sell	7,589 -280	-4%	-$82.7K	0.72%	33
2024 Q4	$2.05M	Buy	7,869 +7	+0.1%	+$2.08K	0.61%	39
2024 Q3	$2.53M	Sell	7,862 -106	-1%	-$34.7K	0.73%	31
2024 Q2	$2.49M	Sell	7,968 -359	-4%	-$105K	0.75%	31
2024 Q1	$2.37M	Sell	8,327 -132	-2%	-$38.6K	0.71%	37
2023 Q4	$2.44M	Sell	8,459 -36	-0.4%	-$9.81K	0.76%	33
2023 Q3	$2.28M	Sell	8,495 -25	-0.3%	-$6.24K	0.75%	32
2023 Q2	$1.89M	Buy	8,520 +8	+0.1%	+$1.86K	0.61%	43
2023 Q1	$2.06M	Sell	8,512 -41	-0.5%	-$10.1K	0.69%	36
2022 Q4	$2.25M	Sell	8,553 -1,100	-11%	-$295K	0.78%	33
2022 Q3	$2.18M	Sell	9,653 -148	-2%	-$35.9K	0.78%	34
2022 Q2	$2.38M	Sell	9,801 -23	-0.2%	-$5.64K	0.79%	34
2022 Q1	$2.38M	Sell	9,824 -65	-0.7%	-$14.9K	0.68%	43
2021 Q4	$2.23M	Sell	9,889 -43	-0.4%	-$9.07K	0.59%	44
2021 Q3	$2.11M	Sell	9,932 -22	-0.2%	-$5.06K	0.64%	41
2021 Q2	$2.43M	Sell	9,954 -50	-0.5%	-$12.3K	0.73%	40
2021 Q1	$2.49M	Hold	10,004	–	–	0.78%	36
2020 Q4	$2.3M	Hold	10,004	–	–	0.75%	35
2020 Q3	$2.54M	Sell	10,004 -23	-0.2%	-$5.7K	0.91%	32
2020 Q2	$2.36M	Sell	10,027 -66	-0.7%	-$15.1K	0.93%	30
2020 Q1	$2.05M	Sell	10,093 -15	-0.1%	-$3.28K	0.87%	32
2019 Q4	$2.44M	Buy	10,108 +3,524	+54%	+$777K	0.93%	30
2019 Q3	$1.27M	Sell	6,584 -22	-0.3%	-$4.22K	0.78%	41
2019 Q2	$1.22M	Hold	6,606	–	–	0.74%	42
2019 Q1	$1.25M	Sell	6,606 -27	-0.4%	-$5.16K	0.79%	38
2018 Q4	$1.29M	Sell	6,633 -218	-3%	-$42.5K	0.91%	33
2018 Q3	$1.42M	Sell	6,851 -7	-0.1%	-$1.38K	0.81%	34
2018 Q2	$1.27M	Sell	6,858 -3	-0%	-$531	0.77%	36
2018 Q1	$1.17M	Sell	6,861 -40	-0.6%	-$7.34K	0.72%	40
2017 Q4	$1.2M	Sell	6,901 -237	-3%	-$41.9K	0.73%	41
2017 Q3	$1.33M	Sell	7,138 -287	-4%	-$50.9K	0.86%	35
2017 Q2	$1.28M	Buy	7,425 +27	+0.4%	+$4.39K	0.85%	36
2017 Q1	$1.21M	Sell	7,398 -156	-2%	-$25.9K	0.84%	37
2016 Q4	$1.1M	Sell	7,554 -25	-0.3%	-$3.76K	0.77%	40
2016 Q3	$1.26M	Hold	7,579	–	–	0.91%	37
2016 Q2	$1.15M	Hold	7,579	–	–	0.87%	35
2016 Q1	$1.14M	Hold	7,579	–	–	0.86%	36
2015 Q4	$1.23M	Sell	7,579 -388	-5%	-$61K	0.93%	33
2015 Q3	$1.1M	Sell	7,967 -106	-1%	-$16.7K	0.86%	37
2015 Q2	$1.24M	Hold	8,073	–	–	0.87%	36
2015 Q1	$1.29M	Sell	8,073 -86	-1%	-$13.5K	0.89%	36
2014 Q4	$1.3M	Buy	8,159 +76	+0.9%	+$11.8K	0.87%	38
2014 Q3	$1.14M	Hold	8,083	–	–	0.79%	40
2014 Q2	$957K	Sell	8,083 -265	-3%	-$30.7K	0.65%	47
2014 Q1	$1.03M	Sell	8,348 -127	-1%	-$15.4K	0.71%	42
2013 Q4	$967K	Sell	8,475 -842	-9%	-$95.8K	0.67%	45
2013 Q3	$1.04M	Sell	9,317 -757	-8%	-$82.1K	0.77%	41
2013 Q2	$994K	Buy	+10,074	New	+$1.05M	0.61%	47

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Roberts, Glore & Co's AMGN Position: Q2 2026 in Review

Roberts, Glore & Co reduced its Amgen (AMGN) stake by 1.7% in Q2 2026, selling an estimated $39.4K and leaving 6,771 shares worth $2.45M. The position accounts for 0.61% of the portfolio, ranked #42.

Roberts, Glore & Co first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.54M in Q3 2020. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Roberts, Glore & Co held 6,771 shares of Amgen worth $2.45M as of Q2 2026.
Roberts, Glore & Co sold 115 Amgen shares in Q2 2026, an estimated $39.4K.
Amgen made up 0.61% of Roberts, Glore & Co's portfolio in Q2 2026, its #42 holding.
Roberts, Glore & Co first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
Roberts, Glore & Co's Amgen position peaked at $2.54M in Q3 2020.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Roberts, Glore & Co's 13F filing for Q2 2026, filed 11 Aug 2026.